ClinicalTrials.gg
RecruitingNCT06902116Updated Jul 6, 2026

Comparison of Outcome of Three Days Bowel Preparation vs No Bowel Preparation in Patients of Colostomy Reversal

An interventional study of No Mechanical Bowel Preparation and Mechanical Bowel Preparation in Colostomy - Stoma, Bowel Preparation and BOWEL ANASTOMOSIS, sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Recruiting at 1 site in Pakistan. Open to participants aged 1 Year to 15 Years. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by University of Child Health Sciences and Children's Hospital, Lahore · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
1 Year to 15 Years
Sex
All
01

Study summary

The goal of this trial is to compare the outcomes of colostomy reversal with three days bowel preparation with no bowel preparation in terms of anastomotic leakage, surgical site infection and hospital stay.

The important question this trial aims to answer is:

1. is there any difference in outcomes after colostomy reversal with three days gut preparation pre-operatively vs no gut preparation?

This prospective Randomized Controlled trial will include children with colostomy divided into two groups:

Group A: No Mechanical Bowel Preparation Group B: 3 Days Mechanical Bowel Preparation Participants of Group A will be admitted 1 day prior to surgery date as they require no special preparation before surgery. They will be made Nil per oral 6 hours prior to surgery. Group B participants will be admitted 3 days prior to surgery. These participants will be restricted to fiber rich diet and milk 72 hours prior to surgery. They will be shifted to clear liquids 24 hours prior to surgery. Normal saline enema will be given 8 hourly through the stoma as well as per rectally by the trained person.

Comparative outcomes will be:

  1. Anastomotic leakage
  2. Hospital Stay
  3. Wound infection
02

Conditions studied

  • Colostomy - Stoma
  • Bowel Preparation
  • BOWEL ANASTOMOSIS
03

In context

Lead sponsor

University of Child Health Sciences and Children's Hospital, Lahore is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children with colostomy between 1-15 years of age

Exclusion criteria

Exclusion Criteria:

  • Malnourished
  • Previous history of colostomy site anastomotic leakage
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Group A Colostomy Reversal

    Patients in this group will not receive any mechanical bowel preparation prior to undergoing colostomy reversal.

    Procedure: No Mechanical Bowel Preparation

  • Active comparator
    Group B Colostomy Reversal

    Patients in this group will receive 3 days bowel preparation prior to undergoing colostomy reversal.

    Procedure: Mechanical Bowel Preparation

Interventions

  • ProcedureNo Mechanical Bowel Preparation

    In this group patients will not receive any mechanical bowel preparation prior to undergoing colostomy reversal.

  • ProcedureMechanical Bowel Preparation

    In this group patients will receive 3 days mechanical bowel preparation prior to undergoing colostomy reversal.

06

What researchers measure

Primary outcomes

  1. Anastomotic Leakage

    In this outcome measure, it will be seen if there is any difference in both intervention in terms of number of participants with anastomotic (part of gut where two separate ends of colon have been sutured with each other) leakage.

    Time frame: 5-10 days post operatively.

  2. Wound infection

    In this outcome variable, number of participants with infection at the site of colostomy reversal wound will be compared between both groups.

    Time frame: At 7 days after surgery and then at 30 days after surgery.

07

Study locations

1 of 1 sites recruiting
  • University of Child Health Sciences, The Children's Hospital
    Lahore, Punjab Province 54600, Pakistan
    Recruiting
    • Muhammad Z Shoukat, MBBS, FCPS · Contactzubairshaukat@outlook.com · 923126446646
    • Aziz Ahmad Chattha, MBBS, FCPS · Principal investigator
08

References and documents

Publications

  • Cavusoglu YH, Karaman A, Afsarlar CE, Karaman I, Erdogan D, Ozguner IF. Ostomy Closures in Children: Variations in Perioperative Care Do Not Change the Outcome. Indian J Surg. 2015 Dec;77(Suppl 3):1131-6. doi: 10.1007/s12262-015-1212-0. Epub 2015 Jan 19. PubMed 27011524 ↗
  • Ares GJ, Helenowski I, Hunter CJ, Madonna M, Reynolds M, Lautz T. Effect of preadmission bowel preparation on outcomes of elective colorectal procedures in young children. J Pediatr Surg. 2018 Apr;53(4):704-707. doi: 10.1016/j.jpedsurg.2017.03.060. Epub 2017 Mar 30. PubMed 28433362 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — all IPD that underlie results in a publication after deidentification (text, table, figures and appendices)

Supporting information: Study protocol, Clinical study report

Time frame: Immediately following publication. No end date.

Access criteria: Data will be available to researchers who provide a methodologically sound proposal in order to achieve the aims mentioned in the approved proposal. Proposals should be directed to email : azizchattha@hotmail.com

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Jan 2027, 24 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2025
First posted
Mar 30, 2025
StartActual
Jan 8, 2025
Primary completionEst.
Jan 2027
CompletionEst.
Mar 2027
Last update
Jul 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06902116
Lead sponsor
University of Child Health Sciences and Children's Hospital, Lahore
Responsible party
Aziz Ahmad Chattha (Senior Registrar, University of Child Health Sciences and Children's Hospital, Lahore) — Principal investigator
First posted
Mar 30, 2025
Start date
Jan 8, 2025
Primary completion
Jan 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Jul 6, 2026

Study contacts

Aziz A Chattha, MBBS, FCPS
Contact
azizchattha@hotmail.com
923215986466

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion